Biomedical Engineering Reference
In-Depth Information
Choi, H.S., Liu, W., Misra, P. et al. 2007. Renal clearance of nanoparticles.
Nat Biotechnol
25:1165-1170.
Choi, H.S., Liu, W., Liu, F. et al. 2010a. Design considerations for tumour-targeted nanoparticles.
Nat
Nanotechnol
5:42-47.
Choi, C.H.J., Zuckerman, J.E., Webster, P., and Davis, M.E. 2011. Targeting kidney mesangium by nanopar-
ticles of defined size.
Proc Natl Acad Sci USA
108:6656-6661.
Clapham, D.E., 2007. Calcium signaling.
Cell
131:1047-1058.
Cooper, J.R., Stradling, G.N., Smith, H., and Breadmore, S.E. 1979. The reactions of 1.0 nanometre diam-
eter plutonium-238 dioxide particles with rat lung fluid.
Int J Radiat Biol Relat Stud Phys Chem Med
36:453-466.
Cristina, B., Ivan, I.P.B., and Kevin, R. 2007. Nanomaterials and nanoparticles: Sources and toxicity.
Biointerphases
2(4):MR17-MR172.
Dan, M., Tseng, M.T., Florence, R.L. et al. 2010. Short- and long-term biodistribution and oxidative stress
effects of a systemically-introduced 5 nm ceria engineered nanomaterial. 49th Annual Meeting (March
7-11, 2010) of the Society of Toxicology, Salt Lake City, UT.
DeJesus, O.L.P., Ihre, H.R., Gagne, L., Frechet, J.M.J., and Szoka, F.C. 2002. Polyester dendritic systems for
drug delivery applications:
In vitro
and
in vivo
evaluation.
Bioconjug Chem
13:453-461.
Del, M.U. 2005. Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to
macromolecular crowding.
Med Hypotheses
64(4):818-825.
Demoy, M., Andreux, J.P., Weingarten, C., Gouritin, B., Guilloux, V., and Couvreur, P. 1999. Spleen capture of
nanoparticles: Influence of animal species and surface characteristics.
Pharm Res
16:37-41.
Deng, X., Jia, G., Wang, H. et al. 2007. Translocation and fate of multi-walled carbon nanotubes
in vivo
.
Carbon
45(7):1419-1424.
Deng, X.Y., Yang, S.T., Nie, H.Y., Wang, H.F., and Liu, Y.F. 2008. A generally adoptable radiotracing method
for tracking carbon nanotubes in animals.
Nanotechnology
19:075101.
Derfus, A.M., Chan, W.C.W., and Bhatia, S.N. 2004. Probing the cytotoxicity of semiconductor quantum dots.
Nano Letters
4(1):11-18.
Dobrovolskaia, M.A., and McNeil, S.E. 2007. Immunological properties of engineered nanomaterials.
Nat
Nanotechnol
2:469-478.
Donaldson, K., Tran, L., Jimenez, L.A. et al. 2005. Combustion-derived nanoparticles: A review of their toxi-
cology following inhalation exposure part.
Fibre Toxicol
2:10.
Doshi, N. and Mitragotri, S. 2010. Macrophages recognize size and shape of their targets.
PLoS One
5:e10051.
Dunford, R., Salinaro, A., Cai, L. et al. 1995. Chemical oxidation and DNA damage catalyzed by inorganic
sunscreen ingredients.
Toxicol Lett
80: 61-67.
El-Ansarty, A. and Al-Daihan, S. 2009. On the toxicity of therapeutically used nanoparticles: An overview.
J Toxicol
1-9, Article ID 754810.
Fabian, E., Landsiedel, R., Ma-Hock, L., Wiench, K., Wohlleben, W., and Van, R.B. 2008. Tissue distribu-
tion and toxicity of intravenously administered titanium dioxide nanoparticles in rats.
Arch Toxicol
82:151-157.
Fischer, H.C., Liu, L., Pang, K.S., and Chan, W.C.W. 2006. Pharmacokinetics of nanoscale quantum dots:
In
vivo
distribution, sequestration, and clearance in the rat.
Adv Funct Mater
16:1299-1305.
Fox, M.E., Szoka, F.C., and Fréchet, J.M.J. 2009. Soluble polymer carriers for the treatment of cancer: The
importance of the molecular architecture.
Acc Chem Res
42:1141-1151.
Fridovich, I. 1978. The biology in oxygen radical.
Science
201:875-888.
Galhardi, C.M., Diniz, Y.S., Faine, L.A. et al. 2004. Toxicity of copper intake: Lipid profile, oxidative stress and
susceptibility to renal dysfunction.
Food Chem Toxicol
42(12):2053-2060.
Gao, W., Liu, W., Christensen, T., Zalutsky, M.R., and Chilkoti, A. 2010.
In situ
growth of a PEG like polymer
from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation.
Proc Natl Acad Sci USA
107:16432-16437.
Gatti, A.M. 2004. Biocompatibility of micro- and nano-particles in the colon. Part II.
Biomaterials
25:385-392.
Gatti, A.M. and Rivasi, F. 2002. Biocompatibility of micro- and nanoparticles. Part I: In liver and kidney.
Biomaterials
23:2381-2387.
Gatti, A.M., Montanari, S., Monari, E. et al. 2004. Detection of micro- and nano-sized biocompatible particles
in the blood.
J Mater Sci Mater Med
15:469-472.
Gauthier, M.A. and Klok, H.A. 2010. Polymer-protein conjugates: An enzymatic activity perspective.
Polym
Chem
1:1352-1373.
Gillian, F., Benjamin, J.S., and Richard, D.H. 2007.
Aquatic Toxicol
84:415-430.
Gong, C., Tao, G., Yang, L., Liu, J., He, H., and Zhuang, Z. 2012. The role of reactive oxygen species in silicon
dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells.
Mol Biol Rep
39:4915-4925.
